{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:36:54Z","timestamp":1780605414172,"version":"3.54.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128986","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T18:01:17Z","timestamp":1433786477000},"page":"e0128986","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00376168","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01411228","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Richat","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Chertkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"PJ Meikle","year":"1999","journal-title":"JAMA"},{"key":"ref2","first-page":"1","article-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"GA Grabowski","year":"2010"},{"key":"ref3","article-title":"The Online Metabolic & Molecular Bases of Inherited Disease","author":"GA Grabowski","year":"2010"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ajh.23399","article-title":"Competing for the treasure in exceptions","volume":"88","author":"TM Cox","year":"2013","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1073\/pnas.75.3.1399","article-title":"Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages","volume":"75","author":"PD Stahl","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"NW Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V93.9.2807","article-title":"A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease","volume":"93","author":"B Friedman","year":"1999","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"GA Grabowski","year":"1995","journal-title":"Ann Intern Med"},{"key":"ref9","article-title":"Cerezyme [package insert]","year":"2009"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bcmd.2007.02.008","article-title":"A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease","volume":"39","author":"A Zimran","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"ref11","article-title":"VPRIV [package insert]","year":"2013"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1467-7652.2007.00263.x","article-title":"Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system","volume":"5","author":"Y Shaaltiel","year":"2007","journal-title":"Plant Biotechnol J"},{"key":"ref13","article-title":"Elelyso [package insert]","year":"2014"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nbt0612-472","article-title":"First plant-made biologic approved","volume":"30","author":"JL Fox","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"A Zimran","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V120.21.2140.2140","article-title":"A multicenter, double-blind, randomized safety and efficacy study of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease [abstract 2140]","volume":"120","author":"A Zimran","year":"2012","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Pastores GM, Petakov M, Giraldo P, Rosenbaum H, Szer J, Deegan PB, et al. (17 June 2014) A phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell expressed reconbinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase. Blood Cells Mol Dis [Epub ahead of print].","DOI":"10.1016\/j.bcmd.2014.05.004"},{"key":"ref18","article-title":"A phase III trial to assess the safety and efficacy of plant cell expressed GCD in patients with Gaucher disease NCT00376168"},{"key":"ref19","article-title":"A multicenter extension study of taliglucerase alfa in pediatric subjects with Gaucher disease. NCT01411228"},{"key":"ref20","article-title":"A safety and efficacy study of two dose levels of taliglucerase alfa in pediatric subjects with Gaucher disease"},{"key":"ref21","article-title":"Switchover trial from imiglucerase to plant cell expressed recombinant human glucocerebrosidase"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1371\/journal.pone.0004792","article-title":"A plant-derived recombinant human glucocerebrosidase enzyme\u2014a preclinical and phase I investigation","volume":"4","author":"D Aviezer","year":"2009","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e10750","DOI":"10.1371\/journal.pone.0010750","article-title":"Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model","volume":"5","author":"YH Xu","year":"2010","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1073\/pnas.1003247107","article-title":"Imaging of enzyme replacement therapy using PET","volume":"107","author":"CP Phenix","year":"2010","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T04:46:59Z","timestamp":1599108419000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128986"}},"subtitle":[],"editor":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128986","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]}}}